These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 24081659

  • 21. Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
    Ammatuna E, Eefting M, van Lom K, Kavelaars FG, Valk PJ, Touw IP.
    Ann Hematol; 2015 May; 94(5):879-80. PubMed ID: 25491280
    [No Abstract] [Full Text] [Related]

  • 22. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
    Price A, Druhan LJ, Lance A, Clark G, Vestal CG, Zhang Q, Foureau D, Parsons J, Hamilton A, Steuerwald NM, Avalos BR.
    Biochem Biophys Res Commun; 2020 Feb 26; 523(1):208-213. PubMed ID: 31848046
    [Abstract] [Full Text] [Related]

  • 23. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y, Chen Y, Li X.
    Ann Hematol; 2021 Jun 26; 100(6):1459-1461. PubMed ID: 33822276
    [Abstract] [Full Text] [Related]

  • 24. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V, Ubezio M, Manes N, Milanesi C, Della Porta M, Bonometti A.
    Leuk Lymphoma; 2023 Sep 26; 64(9):1566-1573. PubMed ID: 37395413
    [Abstract] [Full Text] [Related]

  • 25. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B, Chen X, Gao F, Li J, Wang HW.
    Hematology; 2019 Dec 26; 24(1):538-543. PubMed ID: 31315541
    [Abstract] [Full Text] [Related]

  • 26. Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib.
    Nooruddin Z, Miltgen N, Wei Q, Schowinsky J, Pan Z, Tobin J, Purev E, Gutman JA, Robinson W, Pollyea DA.
    Haematologica; 2017 May 26; 102(5):e207-e209. PubMed ID: 28209656
    [No Abstract] [Full Text] [Related]

  • 27. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC, Szybinski J, Halter JP, Cantoni N, Wenzel F, Leonards K, Brkic S, Passweg JR, Touw I, Maxson JE, Meyer SC.
    Curr Oncol; 2022 Feb 01; 29(2):805-815. PubMed ID: 35200567
    [Abstract] [Full Text] [Related]

  • 28. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
    Gotlib J, Maxson JE, George TI, Tyner JW.
    Blood; 2013 Sep 05; 122(10):1707-11. PubMed ID: 23896413
    [Abstract] [Full Text] [Related]

  • 29. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL.
    PLoS Med; 2006 Jul 05; 3(7):e270. PubMed ID: 16834459
    [Abstract] [Full Text] [Related]

  • 30. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
    Harada S, Okada K, Yokoyama S, Hidaka D, Hayase E, Onozawa M, Goto H, Hashimoto D, Kahata K, Endo T, Teshima T.
    Rinsho Ketsueki; 2021 Jul 05; 62(11):1609-1614. PubMed ID: 34866084
    [Abstract] [Full Text] [Related]

  • 31. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A, Elliott M, Pardanani A.
    Curr Opin Hematol; 2015 Mar 05; 22(2):171-6. PubMed ID: 25575036
    [Abstract] [Full Text] [Related]

  • 32. Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?
    Pardanani A, Tefferi A.
    Leuk Lymphoma; 2014 Dec 05; 55(12):2706-11. PubMed ID: 25520049
    [Abstract] [Full Text] [Related]

  • 33. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y, Qiao C, Chen Y, Zhang SJ.
    Oncotarget; 2017 Mar 28; 8(13):20834-20841. PubMed ID: 28209919
    [Abstract] [Full Text] [Related]

  • 34. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
    Stahl M, Xu ML, Steensma DP, Rampal R, Much M, Zeidan AM.
    Ann Hematol; 2016 Jun 28; 95(7):1197-200. PubMed ID: 27068405
    [No Abstract] [Full Text] [Related]

  • 35. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
    Maxson JE, Luty SB, MacManiman JD, Abel ML, Druker BJ, Tyner JW.
    J Biol Chem; 2014 Feb 28; 289(9):5820-7. PubMed ID: 24403076
    [Abstract] [Full Text] [Related]

  • 36. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.
    Carratt SA, Kong GL, Curtiss BM, Schonrock Z, Maloney L, Maniaci BN, Blaylock HZ, Baris A, Druker BJ, Braun TP, Maxson JE.
    Blood; 2022 Aug 11; 140(6):644-658. PubMed ID: 35482940
    [Abstract] [Full Text] [Related]

  • 37. Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib.
    Lasho TL, Mims A, Elliott MA, Finke C, Pardanani A, Tefferi A.
    Leukemia; 2014 Jun 11; 28(6):1363-5. PubMed ID: 24445868
    [No Abstract] [Full Text] [Related]

  • 38. Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for CSF3R T618I Mutant Chronic Neutrophilic Leukemia.
    Ye P, Lin Q, Jin M, Gu X, Lu Y.
    Turk J Haematol; 2023 Feb 28; 40(1):73-74. PubMed ID: 36510384
    [No Abstract] [Full Text] [Related]

  • 39. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
    Bartels S, Lehmann U, Büsche G, Schlue J, Hussein K, Debatin D, Karcher A, Andrulis M, Schirmacher P, Kreipe H.
    Ann Hematol; 2015 Jul 28; 94(7):1255-6. PubMed ID: 25865944
    [No Abstract] [Full Text] [Related]

  • 40. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq.
    Sheng G, Zhang J, Zeng Z, Pan J, Wang Q, Wen L, Xu Y, Wu D, Chen S.
    Cancer Genet; 2017 Oct 28; 216-217():16-19. PubMed ID: 29025591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.